• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
View Item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Colloids and crystalloids may have similar effects on mortality when used for fluid replacement in critically ill patients

 
Thumbnail
Date
2020-03-16
Author
Allen, Claire
Metadata
Show full item record
Abstract
What is this? Some patients with COVID-19 will become critically ill and may need additional fluids to prevent kidney failure. Fluid replacement options include colloids or crystalloids. Colloids are cheap and easy to use but may increase oedema. Crystalloids cost more, provide swifter volume expansion, but may cause allergic reactions, blood clotting disorders and kidney failure. In this Cochrane systematic review, the authors searched for randomized and quasi-randomized trials, which compared colloid (starches, dextrans, albumin or Fresh Frozen Plasma (FFP)) with crystalloid (isotonic or hypertonic) solutions in patients who were critically ill because of trauma, burns or sepsis and required fluid volume replacement. They did not restrict by date, type or language of publication and did their searches in February 2018. They identified 65 randomised trials and 4 quasi- randomised trials (approximately 30,000 participants). The trials evaluated starch solutions, dextrans, gelatins and albumin or FFP.
URI
https://www.evidenceaid.org/colloids-and-crystalloids-may-have-similar-effects-on-mortality-when-used-for-fluid-replacement-in-critically-ill-patients/
Collections
  • Technical documents and research evidence on COVID-19

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CollectionBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)